Pictet Asset Management (Switzerland)’s Ginkgo Bioworks DNA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$190K	Hold	2,558	–	–	﹤0.01%	1744
2023 Q1	$136K	Hold	2,558	–	–	﹤0.01%	1814
2022 Q4	$173K	Buy	2,558 +1,545	+153%	+$142K	﹤0.01%	1763
2022 Q3	$126K	Hold	1,013	–	–	﹤0.01%	1453
2022 Q2	$96K	Buy	+1,013	New	+$124K	﹤0.01%	1489

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s DNA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Ginkgo Bioworks (DNA) position steady in Q2 2023 at 2,558 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Pictet Asset Management (Switzerland) first reported a position in DNA in Q2 2022 and has held it in 5 quarters since. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

Pictet Asset Management (Switzerland) held 2,558 shares of Ginkgo Bioworks worth $190K as of Q2 2023.
Pictet Asset Management (Switzerland) left its Ginkgo Bioworks share count unchanged in Q2 2023.
Ginkgo Bioworks made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1744 holding.
Pictet Asset Management (Switzerland) first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 5 quarters since.
315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.